TargetDx Laboratory

What You Can Expect from TargetDx

TargetDx laboratory leverages cutting-edge technologies and leading scientific experts to deliver world-class clinical testing. We are pleased to offer COVID-19 diagnostic, COVID-19 antibody and lung cancer diagnostic testing.

At least 70% of medical decisions are based in laboratory results. TargetDx strives to provide fast, accurate and confidential results to support the doctors at hospitals and clinics across California.

Reading Results

Trust the Lab Result

At TargetDx, we follow the industry highest standards in providing accurate results and quick turnaround time. We utilize tests that are approved for use under FDA’s Emergency Use Authorization (EUA) and follow the strict CLIA guidelines for Laboratory Developed Tests.

Temperature check

Access COVID-19 Testing Near You

Call your doctor if you experience symptoms or have been in contact with a confirmed case. Your doctor can answer questions regarding your health concerns. At TargetDx, we provide COVID-19 viral and antibody testing as well as early-stage lung cancer diagnosis.

Make an APPOINTMENT NOW by calling us at  219-510-0120 or email us at info@targetdxlab.com

Patient Portal

The TargetDx Patient Portal allows for ordering of test, receiving test results, and providing explanation of test results. The Portal can be accessed via desktop, tablet, or mobile device. As a registered user of TargetDx Laboratory, you will have access to your test results immediately after they are released.

Health Insurance Card

Is This Covered by Insurance?

All comprehensive health insurance plans are required to cover 100% of the cost of COVID-19 testing. Comprehensive health plans are individual, employer-sponsored or exchange plans that meet the coverage requirements stipulated in the Affordable Care Act. If you’re insured by a short-term plan or another plan that isn’t compliant with Affordable Care Act, your insurer may not cover the costs associated with your test.

Insurers must also provide free antibody testing under the Coronavirus Aid, Relief and Economic Security (CARES) Act.